Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome

This study has been completed.
Sponsor:
Collaborators:
Genentech
Tanox
Information provided by (Responsible Party):
Altor Bioscience Corporation
ClinicalTrials.gov Identifier:
NCT01438853
First received: September 20, 2011
Last updated: September 21, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
No publications provided by Altor Bioscience Corporation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):